Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii

Clin Microbiol Infect. 2004 Dec;10(12):1098-101. doi: 10.1111/j.1469-0691.2004.00987.x.

Abstract

The interaction between sulbactam and imipenem was evaluated with four clinical isolates of Acinetobacter baumannii, including two isolates resistant to imipenem, one of which produced IMP-1 metallo-beta-lactamase. Two isolates (one of which was imipenem-resistant) were sulbactam-resistant by undefined mechanisms. MICs were determined by standard broth microdilution methods. Time-kill assays with imipenem and sulbactam, alone or in combination at 0.5 x MIC and 1 x MIC, showed a synergic effect in all four isolates of A. baumannii after incubation for 0, 4, 8 and > 24 h at 35 degrees C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter baumannii / drug effects*
  • Anti-Bacterial Agents / pharmacology*
  • Drug Synergism
  • Imipenem / pharmacology*
  • Microbial Sensitivity Tests
  • Sulbactam / pharmacology*
  • Time Factors
  • beta-Lactamase Inhibitors*

Substances

  • Anti-Bacterial Agents
  • beta-Lactamase Inhibitors
  • Imipenem
  • Sulbactam